Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial

Sponsor
Centro de Atenção ao Assoalho Pélvico (Other)
Overall Status
Recruiting
CT.gov ID
NCT03075046
Collaborator
Vitale SG M.D. (Other), University of Messina (Other)
40
1
3
79.4
0.5

Study Details

Study Description

Brief Summary

Vulvovaginal candidiasis (CVV) is an infectious process of the female genitourinary tract, an important health issue due to the high incidence and difficulties encountered in the treatment. Therefore, new therapeutic modalities are sought with the capacity to minimize drug side-effects and to reduce recurrent cases. The objective of this stufy is to evaluate the clinical and microbiological response of the 405 nm blue light emitting diode in the treatment of women with vulvovaginal candidiasis and in women with healthy gentourine treatment. A clinical trial was conducted involving 40 women, divided into two groups, the first group consisting of women with a confirmed CVV diagnosis and a second group formed by women with a healthy genitourinary tract, without symptoms and symptoms of the disease. Both groups underwent clinical evaluation and examination with endocervice collection with gynecologist before and after a session of application of the Blue Light Emitting Diode of 405 nm, lasting 4.5 minutes. There will also be an evaluation of the effects of the diary through the questionnaire answered before and after the participants' treatment. It is expected that the 405 nm blue LED will destroy the CVV fungus demonstrated by laboratory examination and also improve the signs and results analyzed by the gynecologist and participants.

Condition or Disease Intervention/Treatment Phase
  • Device: Blue LED 405 nm
  • Other: Questionnaire of anamnesis
N/A

Detailed Description

A current treatmente proposal is the use of blue LED of 405 nm wich is a light that has antimicrobial effect when exposed to endogenous porphyrin of the pathogens. This exposition produces reactive oxigen and it causes cells death with no possibilities of resistance by the fungus.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Use of 405nm Blue Light Emitting Diode in the Treatment of Women With Vulvovaginal Candidiasis: a Clinical Trial
Actual Study Start Date :
Apr 20, 2017
Actual Primary Completion Date :
Feb 20, 2018
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: blue LED 405 nm in vulvovaginal candidiasis

It will be applied the a 405 nm blue LED in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session. This part of the study will see if there is fungicidal effect of the blue led 405 nm

Device: Blue LED 405 nm
It will be applied a 405 nm blue Tonderm LED with a power of 1.66 W / m2, in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session.

Other: Questionnaire of anamnesis
The participants will answer the anamnesis Questionnaire that will be applied by the physiotherapist

Experimental: blue LED 405 nm in healthy women

It will be applied the a 405 nm blue LED in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session.This part of the study will see the security and the effects of the blue led 405 nm in healthy vaginal microflora

Device: Blue LED 405 nm
It will be applied a 405 nm blue Tonderm LED with a power of 1.66 W / m2, in a closed room by a physiotherapist for 30 minutes. The apparatus shall be supported on a tripod, statically, externally, 5 cm away from the vulva and vagina region, with the patient naked, in gynecological stretcher and lithotomy position. The protocol will consist of only one session.

Other: Questionnaire of anamnesis
The participants will answer the anamnesis Questionnaire that will be applied by the physiotherapist

No Intervention: Sociodemographic data of women with vulvovaginal candidiasis

The women will answer some questions of the anamnesis as: Age, weight, height, form of intimate hygiene, and others to evaluate possible correlations of these data with the presence of vulvovaginal candidiasis

Outcome Measures

Primary Outcome Measures

  1. Description of types of cells done by oncology and microflora cytology in women treated by blue light emitting diode [15 days]

    These exam will be done by the collect of vaginal secretion to analyse types of cells and organisms

  2. Amount of clue cells quantified by fresh citology in vaginal secretion of women treated by blue light emitting diode [5 hours]

    These exam will be done by the collect of vaginal secretion using KOH 10% to analyse clue cells by percentage %

  3. Value of vaginal pH measurement in women treated by blue light emitting diode [30 minutes]

    These exam will be done by the collect of vaginal secretion using a ph measuring tape to analyse the hydrogen potential in -log10 [aH+] in women treated by blue light emitting diode. It will be used the numeric scale of pH value

  4. Quantification of fungal colony units by the fungus culture in vaginal secretion of women treated by blue light emitting diode [15 days]

    These exam will be done by the collect of vaginal secretion using Colony Forming Unit CFU in women treated by blue light emitting diode

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • women betwen 18 and 65 years old, with clinical suspect of vulvovaginal candidiasis and with health vaginal tract
Exclusion Criteria:
  • Women with pacemakers, with diagnosis and / or suspicion of neoplasias, cognitive deficits, neurological and / or psychiatric diseases, pregnant women and women who have used oral antibiotics, fungicides, corticosteroids and vaginal creams in the last 30 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro de Atenção ao Assoalho Pelvico Salvador Ba Brazil 40.290-000

Sponsors and Collaborators

  • Centro de Atenção ao Assoalho Pélvico
  • Vitale SG M.D.
  • University of Messina

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centro de Atenção ao Assoalho Pélvico
ClinicalTrials.gov Identifier:
NCT03075046
Other Study ID Numbers:
  • CentroAAP
First Posted:
Mar 9, 2017
Last Update Posted:
Feb 8, 2022
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centro de Atenção ao Assoalho Pélvico
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 8, 2022